These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 7556281)
1. Extra-pelvic metastasis of endometrioid carcinoma; resistance to chemo-radiation therapy--response to paclitaxel treatment. Case report. Hornreich G; Hiller N; Neuman M; McDaniel C; Winograd B; Lavie O; Beller U Eur J Gynaecol Oncol; 1995; 16(4):263-7. PubMed ID: 7556281 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant Carboplatin and Paclitaxel Chemotherapy Followed by Radiotherapy in High-Risk Endometrial Cancer: A Retrospective Analysis. Rodrigues da Cunha Colombo Bonadio R; Gondim Meira Velame Azevedo R; Harada G; Cabral Severino da Costa S; Costa Miranda V; de Freitas D; Abdo Filho E; Alves de Oliveira Ferreira P; Gabrielli F; Del Pilar Estevez Diz M J Glob Oncol; 2018 Sep; 4():1-8. PubMed ID: 30241227 [TBL] [Abstract][Full Text] [Related]
3. Complete remission of an endometrial carcinoma with bilateral multiple pulmonary and extrapelvic metastases treated by surgery and chemotherapy consisting of paclitaxel and carboplatin. Gücer F; Yilmaz O; Balkanli-Kaplan P; Ali Yüce M Int J Gynecol Cancer; 2005; 15(6):1160-2. PubMed ID: 16343202 [TBL] [Abstract][Full Text] [Related]
4. [Successful treatment of endometrial carcinoma associated with lung metastasis by paclitaxel and carboplatin chemotherapy]. Tohya T; Onoda C; Yoshimura T; Kagami T Gan To Kagaku Ryoho; 2004 Jun; 31(6):949-51. PubMed ID: 15222119 [TBL] [Abstract][Full Text] [Related]
5. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma. Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614 [TBL] [Abstract][Full Text] [Related]
6. A case with three different synchronous primaries of the female genital system and their treatment. Kilciksiz S; Gokce T; Somali I; Uysal D; Baloglu A; Yigit S J BUON; 2007; 12(2):291-3. PubMed ID: 17600888 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous pneumothorax after intensive chemotherapy in endometrial cancer: a rare complication. Chen JR; Yang YC Taiwan J Obstet Gynecol; 2014 Jun; 53(2):245-7. PubMed ID: 25017278 [TBL] [Abstract][Full Text] [Related]
8. A phase 2 trial of radiation therapy with concurrent paclitaxel chemotherapy after surgery in patients with high-risk endometrial cancer: a Korean Gynecologic Oncologic Group study. Cho H; Nam BH; Kim SM; Cho CH; Kim BG; Ryu HS; Kang SB; Kim JH Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):140-6. PubMed ID: 25015202 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant treatment with concomitant radiotherapy and chemotherapy in high-risk endometrial cancer: a clinical experience. De Marzi P; Frigerio L; Cipriani S; Parazzini F; Busci L; Carlini L; Viganò R; Mangili G Gynecol Oncol; 2010 Mar; 116(3):408-12. PubMed ID: 20022359 [TBL] [Abstract][Full Text] [Related]
10. Chemotherapy reduces para-aortic node recurrences in endometrial cancer with positive pelvic and unknown para-aortic nodes. Bogani G; Cromi A; Serati M; Di Naro E; Donadello N; Casarin J; Nardelli F; Ghezzi F Int J Gynecol Cancer; 2015 Feb; 25(2):263-8. PubMed ID: 25486102 [TBL] [Abstract][Full Text] [Related]
12. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients. Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223 [TBL] [Abstract][Full Text] [Related]
13. [Individualized therapy of synchronous ovarian and colon cancers with lymph]. Deme D; Bishr AM; Nizar J; Telekes A Orv Hetil; 2015 Jun; 156(23):939-43. PubMed ID: 26027602 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy between paclitaxel/carboplatin and doxorubicin/cisplatin for concurrent chemoradiation in intermediate- or high-risk endometrioid endometrial cancer: a single institution experience. Kim HS; Kim JW; Wu HG; Chung HH; Park NH; Song YS; Kang SB; Lee HP J Obstet Gynaecol Res; 2010 Jun; 36(3):598-604. PubMed ID: 20598043 [TBL] [Abstract][Full Text] [Related]
15. 3-hour infusion of single-agent paclitaxel for recurrent ovarian cancer. Ishikawa H; Nakanishi T; Nawa A; Suzuki Y; Kuzuya K Int J Clin Oncol; 2001 Jun; 6(3):128-31. PubMed ID: 11706781 [TBL] [Abstract][Full Text] [Related]
16. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Onda T; Yoshikawa H; Mizutani K; Mishima M; Yokota H; Nagano H; Ozaki Y; Murakami A; Ueda K; Taketani Y Br J Cancer; 1997; 75(12):1836-41. PubMed ID: 9192991 [TBL] [Abstract][Full Text] [Related]
17. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases]. Ma SK; Zhang HT; Sun YC; Wu LY Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel. An update of its use in the treatment of metastatic breast cancer and ovarian and other gynaecological cancers. Wiseman LR; Spencer CM Drugs Aging; 1998 Apr; 12(4):305-34. PubMed ID: 9571394 [TBL] [Abstract][Full Text] [Related]
20. Current status of chemotherapy in gynecologic cancer. Tropé C; Kristensen G Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216 [No Abstract] [Full Text] [Related] [Next] [New Search]